{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:29:05Z","timestamp":1789874945261,"version":"4.0.1"},"reference-count":23,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There is a paucity of data regarding racial disparities in the survival of patients with indolent non\u2010Hodgkin lymphomas (iNHL) in the contemporary time\u2010period. Hence, we sought to determine whether racial disparities exist in the survival of patients with iNHLs in the US. We included 68\u2009059 adult patients with follicular lymphoma (FL,\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u200941\u2009943), marginal zone lymphoma (MZL,\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u200922\u2009485), and lymphoplasmacytic lymphoma\/Waldenstr\u00f6m macroglobulinemia (LPL\/WM,\n                    <jats:italic>n<\/jats:italic>\n                    \u00a0=\u20093631) who were diagnosed in the US between 2000 and 2017. Race was categorized as White, Black, Asian\/Pacific Islander, or American Indian\/Alaska Native (API\/AI). The primary outcome was relative survival (RS), which was estimated using flexible parametric survival models. The RS estimates varied according to race and disease histology but were consistently lower for racial minorities, including those diagnosed during the most recent 5\u2010year time\u2010period of 2012\u20132017. On multivariable analysis for RS, Black patients with FL had a 32% higher excess mortality rate compared to White patients [adjusted excess hazard ratio (aEHR), 1.32; 95% CI, 1.15\u20131.51;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&lt;\u2009.001], corresponding to a difference of 55 (95% CI, 24\u201386) excess deaths per 10\u00a0000 person\u2010years. For MZL, Black patients had a 40% higher excess mortality rate compared to White patients (aEHR 1.40; 95% CI, 1.18\u20131.66;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&lt;\u2009.001), corresponding to a difference of 62 (95% CI, 26\u201398) excess deaths per 10\u00a0000 person\u2010years. No significant racial differences were detected for patients with WM. The greatest disparity was seen for younger Black patients with FL. Our findings highlight the need for interventions to improve the outcomes of Black patients with iNHLs, particularly younger Black patients with FL.\n                  <\/jats:p>","DOI":"10.1002\/ajh.26198","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T13:55:59Z","timestamp":1618667759000},"page":"816-822","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Racial disparities in the survival of patients with indolent\n                    <scp>non\u2010Hodgkin<\/scp>\n                    lymphomas in the United States"],"prefix":"10.1002","volume":"96","author":[{"given":"John L.","family":"Vaughn","sequence":"first","affiliation":[{"name":"Division of Hematology and Medical Oncology Weill Cornell Medicine  New York New York USA"},{"name":"Clinical Epidemiology and Health Services Research Program Weill Cornell Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Spies","sequence":"additional","affiliation":[{"name":"Cornell University  Ithaca New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-3798","authenticated-orcid":false,"given":"Ana C.","family":"Xavier","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Children's of Alabama\/University of Alabama at Birmingham  Birmingham Alabama USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[{"name":"Division of Hematology The Ohio State University  Columbus Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23914"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2014.12.001"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23708"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360992"},{"key":"e_1_2_10_9_1","unstructured":"US Census Bureau.Projected race and hispanic origin: main projections series for the United States;2017; 2017\u20102060.https:\/\/www.census.gov\/data\/tables\/2017\/demo\/popproj\/2017-summary-tables.html. Accessed October 27 2020."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778225"},{"key":"e_1_2_10_11_1","unstructured":"National Cancer Institute.Number of persons by race and hispanic ethnicity for SEER participants (2010 Census Data);2020.https:\/\/seer.cancer.gov\/registries\/data.html. Accessed July 20 2020."},{"key":"e_1_2_10_12_1","unstructured":"National Cancer Institute.Documentation for the expected survival life tables;2020.https:\/\/seer.cancer.gov\/expsurvival\/documentation.html. Accessed September 3 2020."},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1203"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3064"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq366"},{"key":"e_1_2_10_16_1","unstructured":"National Cancer Institute.SEER cause\u2010specific death classification;2020.https:\/\/seer.cancer.gov\/causespecific\/. Accessed September 2 2020."},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.07.002"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27513"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1102246"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.07.002"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28030"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-839035"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1546855"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.727415"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.26198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:57:17Z","timestamp":1693097837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.26198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1002\/ajh.26198"],"URL":"https:\/\/doi.org\/10.1002\/ajh.26198","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"2021-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}